Maple Capital Management Inc. lifted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 32,436 shares of the healthcare conglomerate’s stock after acquiring an additional 724 shares during the quarter. UnitedHealth Group makes up approximately 2.1% of Maple Capital Management Inc.’s portfolio, making the stock its 19th biggest position. Maple Capital Management Inc.’s holdings in UnitedHealth Group were worth $8,080,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Oregon Public Employees Retirement Fund boosted its holdings in shares of UnitedHealth Group by 50,446.5% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 53,349,795 shares of the healthcare conglomerate’s stock valued at $214,000 after acquiring an additional 53,244,249 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of UnitedHealth Group by 3.1% during the 4th quarter. BlackRock Inc. now owns 69,831,381 shares of the healthcare conglomerate’s stock valued at $17,396,391,000 after acquiring an additional 2,123,417 shares in the last quarter. Rehmann Capital Advisory Group boosted its holdings in shares of UnitedHealth Group by 26,088.2% during the 3rd quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock valued at $6,477,000 after acquiring an additional 1,716,605 shares in the last quarter. Vanguard Group Inc boosted its holdings in shares of UnitedHealth Group by 1.6% during the 3rd quarter. Vanguard Group Inc now owns 69,342,549 shares of the healthcare conglomerate’s stock valued at $18,447,892,000 after acquiring an additional 1,073,505 shares in the last quarter. Finally, Morgan Stanley boosted its holdings in shares of UnitedHealth Group by 18.1% during the 3rd quarter. Morgan Stanley now owns 6,495,072 shares of the healthcare conglomerate’s stock valued at $1,727,948,000 after acquiring an additional 996,515 shares in the last quarter. 86.68% of the stock is currently owned by institutional investors.
UNH has been the topic of several recent research reports. Credit Suisse Group reissued a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a report on Friday, February 8th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a report on Friday, January 11th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 target price on the stock in a report on Saturday, January 5th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $310.00 target price on shares of UnitedHealth Group in a report on Tuesday, January 15th. Finally, Bank of America reaffirmed a “buy” rating and set a $290.00 target price (down from $320.00) on shares of UnitedHealth Group in a report on Wednesday. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $291.56.
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.60 by $0.13. The company had revenue of $60.30 billion for the quarter, compared to the consensus estimate of $59.72 billion. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the business earned $3.04 EPS. On average, equities research analysts forecast that UnitedHealth Group Inc will post 14.63 EPS for the current fiscal year.
In other news, Director Gail R. Wilensky sold 2,930 shares of the business’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the transaction, the director now directly owns 64,726 shares of the company’s stock, valued at approximately $16,400,921.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the business’s stock in a transaction dated Tuesday, March 12th. The shares were sold at an average price of $245.01, for a total value of $1,225,050.00. Following the completion of the transaction, the director now directly owns 182,372 shares in the company, valued at $44,682,963.72. The disclosure for this sale can be found here. Insiders sold a total of 17,930 shares of company stock worth $4,587,133 over the last three months. 0.87% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: This news story was originally reported by Baseball Daily News and is the sole property of of Baseball Daily News. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this news story can be accessed at https://www.baseballdailydigest.com/news/2019/04/21/maple-capital-management-inc-purchases-724-shares-of-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Further Reading: Intrinsic Value and Stock Selection
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.